Determinants of Hemolytic Uremic Syndrome in children under five years of agein Argentina

Authors

  • Leila Vanela López Universidad Abierta Interamericana, Facultad De Medicina Y Ciencias De La Salud, Carrera De Medicina. Buenos Aires. Argentina Author
  • Jorge Eduardo Larcamon Universidad Abierta Interamericana, Facultad De Medicina Y Ciencias De La Salud, Carrera De Medicina. Buenos Aires. Argentina Author

DOI:

https://doi.org/10.56294/shp2025224

Keywords:

Hemolytic-Uremic Syndrome, Argentina, Food Ingestion, Child

Abstract

Introduction: hemolytic uremic syndrome (HUS), associated with Shiga toxin-producing Escherichia coli (STEC), is a leading cause of acute renal failure in children under five years of age. In Argentina, its high incidence reflects challenges in access to drinking water, food hygiene and health education.
Objective: to evaluate the determinants of the incidence of HUS in Argentine children, focusing on hygiene practices, food consumption, access to water and knowledge of caregivers.
Method: observational and descriptive study with three phases: literature review, survey to 33 parents of children <5 years old (food habits, hygiene, knowledge of HUS) and comparative analysis with data from the National Epidemiological Bulletin.
Results: 90,9 % of respondents resided in urban areas, with access to treated water (81,8 %) and high hygiene practices (84,8 % hand washing). However, risks persist: 48,5 % consume unpasteurized products, 33,3 % do not use separate cutting boards and 30,3 % do not know about HUS. The Bulletin highlights higher incidence in rural areas with poor infrastructure and in hot seasons. Cross-contamination and food handling in restaurants were factors highlighted.
Conclusions: the incidence of HUS in Argentina is linked to gaps in the rigorous implementation of hygiene practices, unequal access to drinking water and lack of knowledge about prevention. Educational campaigns, improvement of sanitary infrastructure and food controls are recommended, especially in vulnerable areas and during periods of higher risk. The integration of public policies and community education could reduce the burden of the disease in the child population. 

References

Kliegman RM, Blum NJ, Shah SS, St Geme JW III, Tasker RC, Wilson KM. Nelson Tratado de Pediatría. 21.ª ed. Elsevier; 2020.

Fernández G, Amelotti L, Nicolau V, Vallone A, Altschuler A, Buoro E, et al. Informe Encefalitis Equina del Oeste. Boletín Epidemiológico Nacional. 2024;(702).

Liu Y, Thaker H, Wang C, Xu Z, Dong M. Diagnosis and treatment for Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome. Toxins (Basel) [Internet]. 2022 Jan 1 [cited 2024 Oct 22];15(1):10. Available from: https://www.mdpi.com/2072-6651/15/1/10

Fakhouri F, Schwotzer N, Frémeaux-Bacchi V. How I diagnose and treat atypical hemolytic uremic syndrome. Blood. 2023 Mar 2;141(9):984–95.

Oderiz S, Leotta GA, Galli L. Detección y caracterización de Escherichia coli productor de toxina Shiga en niños atendidos en un hospital pediátrico interzonal de la ciudad de La Plata. Rev Argent Microbiol [Internet]. 2018 [cited 2024 Oct 22];50(4):341–50. Available from: https://www.elsevier.es/es-revista-revista-argentina-microbiologia-372

Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol. 2011;2011:908320.

Eymann A, Coccia P, Raddavero C, Lafi G, Ferraris V, Ramírez J, et al. Prevalence and clinical course of typical hemolytic uremic syndrome among siblings. Arch Argent Pediatr. 2016 Dec;114(6):549–56.

Belardo M. Epidemiological surveillance: caught up in the instrumental logic. The case of Hemolytic Uremic Syndrome in Argentina [Internet]. Buenos Aires; 2013 Mar. Available from: http://www.ea-journal.com

Ministerio de Salud de la Nación. Programa Nacional de Prevención del Síndrome Urémico Hemolítico. Buenos Aires: Ministerio de Salud; [s.f.].

Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, et al. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol [Internet]. 2020;35:1749–59. Available from: https://link.springer.com/article/10.1007/s00467-020-04564-5

Ministerio de Salud de la Nación. Campaña Nacional de Prevención del Síndrome Urémico Hemolítico: Importancia, Prevención y Seguimiento. Buenos Aires: Ministerio de Salud; [s.f.].

Eymann A, Coccia P, Raddavero C, Lafi G, Ferraris V, Ramírez J, et al. Prevalencia y evolución clínica del síndrome urémico hemolítico típico entre hermanos. Arch Argent Pediatr [Internet]. 2016 Dec [cited 2024 Oct 29];114(6):553–6. Available from: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752016000600013

Fernandez-Brando RJ, Bentancor LV, Mejías MP, Panek AC, Cabrera GG, Exeni RA, et al. Escherichia coli productor de toxina Shiga. Medicina (B Aires). 2011;71:383–9.

Downloads

Published

2025-04-25

How to Cite

1.
López LV, Larcamon JE. Determinants of Hemolytic Uremic Syndrome in children under five years of agein Argentina. South Health and Policy [Internet]. 2025 Apr. 25 [cited 2025 Aug. 19];4:224. Available from: https://shp.ageditor.ar/index.php/shp/article/view/224